Role of anti-diabetic medications in the management of MASLD

The use of anti-diabetic medications such as pioglitazone or GLP-1 receptor agonists in the management of metabolic dysfunction-associated steatotic liver disease (MASLD) is discussed in this podcast. Dr Oliver Tavabie, Deputy Editor at FG and Hepatology Consultant at the Leeds Liver Unit, interviews Drs Scott Isaacs and Paul Brennan. Dr Scott Isaacs is the President of the American Association of Clinical Endocrinology and an Adjunct Associate Professor at Emory University School of Medicine, US. Dr Paul Brennan is a Senior Registrar and Honorary Research Fellow in Hepatology based at Ninewells Hospital, UK. They are authors of the paper " Role of anti-diabetic medications in the management of MASLD ”, published online in Frontline Gastroenterology in February 2025. We hope you enjoy the . Please follow @‌FrontGastro_BMJ . Listen to our regular podcasts and

You can listen to Role of anti-diabetic medications in the management of MASLD online on Radio and Podcast. Open the player on this page to stream the available audio.

Role of anti-diabetic medications in the management of MASLD is an episode from FG podcast by BMJ Group.

This episode is 22:30 long.

This episode was published on May 28, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from FG podcast when more episodes are available from the podcast feed.